1 |
D.Taheri. A.Chehrei. M.Fesharakizadeh et al : Transplantation Proceedings. Vol.39, Issue 4. May : 1063, 2007.
|
2 |
Caillard. Sophie 1. Agodoa, Lawrence Y et al : Transplantation. 81(6) :888-895. March 27. 2006
DOI
ScienceOn
|
3 |
Bergsagel. D.E.: Plasma cell myeloma: biology and treatment. Annual Review of Medicine: 42, 1991.
|
4 |
Smith KA. Lachman LB, Oppenheim JJ et al : The functional relationship of the interleukins. J. Exp. Med. : 1551, 1980.
|
5 |
Boyce BF, Xing L : Biology of RANK, RANKL, and osteoprotegerin.. Arthritis Res. Ther. 9:2007.
|
6 |
International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies. multiple myeloma and related disorders : a report of the International Myeloma Working Group. Br. J. Haematol: 74, 2003.
|
7 |
Richard Ravel : Clinical laboratory Medicine. Philadelphia, Mosby: 349. 1995.
|
8 |
Peter H. John M, Janice P et al : Neoplastic Diseases of the Blood. 4th ed. Cambridge, Press Syndicate of the University of Cambridge : 482, 2003.
|
9 |
Attal M, Harousseau J L, Stoppa A M: Autologous bone marrow transplantation versus conventional chemotherapy in multiple myeloma. A prospective, randomized trial. N Engl Med. : 22591, 1997.
|
10 |
Cavenagh J D. Oakervee H : thalidomide in multiple myeloma. Current status and future prospects. Br J Haematol : 120, 2003.
|
11 |
Int. J. Radiation Oncology BioI. Phys. : Vol.50: 1131 2007.
|
12 |
Pei Lin MD : Plasma cell myeloma. Hematology Oncology Clinics of North America Volume 23 : Issue 4 August, 2009.
|
13 |
Oral surgery, oral medicine, oral pathology and endodontology : 103, 2007.
|
14 |
Anderson KC, Saughnessy JD, Barlogie B : Multiple myeloma. Hematology: 214, 2002.
|